Skip to main content
OpenTrials
Completed

NCT Number: NCT03059732

Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan

The differences in patient's clinicopathological characteristic between high and low prevalence of gastric cancer region should be further examined to elucidate factors that associate with poor survival rate of patients with gastric cancer. Therefore, this study aimed to evaluate characteristics of patients with gastric adenocarcinoma and factors associated with different outcome in Thailand and Japan to find a clue to improve patients' survival in low prevalence country such as Thailand.

This is a retrospective cohort study. It was conducted at King Chulalongkorn Memorial Hospital, Thailand and Osaka Medical Center for Cancer and Cardiovascular Disease, Japan. Eligible cases were selected by using standardized search protocols: formal computer searches of all patients seen at out-patient clinic and/or hospitalized for gastric cancer between 2010 and 2014.Two physicians, who were informed the definition of each variable, individually reviewed chart of patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

King Chulalongkorn Memorial Hospital

Bangkok, Patum Wan, 10330, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients seen at out-patient clinic and/or hospitalized for gastric cancer between 2010 and 2014.

Exclusion criteria

  • Age < 18 years
  • Incomplete data
  • Miss diagnosis of gastric adenocarcinoma
  • Died from other causes (not related to gastric adenocarcinoma).

Treatment and study plan

Treatment

Other

Observe the treatments of gastric cancer in each group

Primary outcomes

  1. Factors that associated with mortality rate in Thailand compared to Japan

    Time frame: 2010-2014

Sponsors and collaborators

Lead sponsor

King Chulalongkorn Memorial Hospital

Other

Collaborators

  • Osaka Medical Center for Cancer and Cardiovascular Diseases

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Feb 23, 2017
Registry last updated
Feb 27, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.